Oğuzcan Özkan

7PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Peripheral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 31, 2025
Skeletal muscle index as a prognostic biomarker for survival in HER2-positive and triple-negative breast cancer: a retrospective cohort study.

Oğuzcan Özkan, Aslı Geçgel, Sevgi Erol

|Dec 24, 2025
Real-World Predictors of Survival in CDK4/6 Inhibitor-Treated Metastatic Breast Cancer: The Significance of ER Expression Level and Treatment Naivety.

Büşra Bülbül, Bekir Ucun, Can Cangür

|Oct 29, 2025
Efficacy of Subsequent Therapy in Patients with Hormone-Positive Advanced Breast Cancer with Disease Progression After CDK4/6 Inhibitor Therapy: Multicenter Real-Life Data.

Buket Şahin Çelik, Aslı Geçgel, Oğuzcan Özkan

|Sep 27, 2025
Systemic Immune-Inflammation Index as a Prognostic Marker in Gastric and Gastroesophageal Junction Cancers Receiving Perioperative FLOT Therapy.

Pinar Peker, Asli Geçgel, Oğuzcan Özkan

|Jun 13, 2025
Prognostic Power of the Naples Score in Non-Small Cell Lung Cancer: Can Inflammation and Nutrition Predict Survival?

Pınar Peker, Aslı Geçgel, Alpay Düşgün

|Apr 26, 2025
Prognostic Value of Preoperative Lymphocyte-to-Monocyte Ratio in Patients with Recurrent Colorectal Cancer.

Oğuzcan Özkan, Pınar Peker, Aslı Geçgel

Pageof 2

Frequent Collaborators

5 joint publications

Aslı Geçgel

3 joint publications

Pınar Peker

2 joint publications

Alpay Düşgün

2 joint publications

Erhan Gökmen